Skip to main content
OpenTrials
Completed

NCT Number: NCT06465225

Prevention of Pressure Ulcers in Patients at Medium to High Risk of Pressure Ulcers Using the R'GO SOINS Overlay Mattress

The aim of the study is to determine the clinical value of using a powered alternating pressure air overlay mattress (P-APAM) in the prevention of pressure injury (PI) in patients at medium to high risk.

This study is noncomparative, observational study.

Patients older than 18 years of age, with a medium to high risk of PI, without PI, up during the day, and lying between 15 and 20 hours per day on a specific P-APAM will be included. The study will be conducted in nursing homes, and in long-stay geriatrics department.

Patients will be followed up for 35 days. The use of the P-APAM is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who will develop at least one PI of at least stage 2 on the sacrum, spine, or heel between day 0 and day 35 . Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Multiples Facilities

Multiple Locations, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over 18 years old
  • Patient with a medium to high risk of developing pressure ulcers (clinical judgment and a score of [10 to 14] on the Braden scale (6 (maximum risk) to 23 (no risk))
  • Patient without pressure injury on the day of inclusion
  • Patient up during the day and lying down for more than 15 hours and less than 20 hours per day on an R'GO SOINS overlay mattress for less than 48 hours or since the day of inclusion
  • Patient with a weight < 150kg
  • Patient (or a trusted third party/legal representative) having been informed of the study and signing informed consent

Exclusion criteria

  • Patient at end of life (estimated life expectancy less than 6 months)
  • Patient discharge from the establishment expected within two months
  • Patient already installed on an R'GO SOINS mattress topper for more than 48 hours before inclusion
  • Patient with unstable spinal injury or other spinal disorder
  • Patient with cervical or skeletal traction
  • Patient with unstable spinal cord injury
  • Patient with acute multiple trauma
  • Patient with unstable posttraumatic bone fracture
  • Participants will be excluded from the study if they meet the following combination of criteria indicative of malnutrition according to the 2021 French National Authority for Health guidelines (Participants must meet at least one phenotypic criterion and one etiological criterion to be considered malnourished and therefore ineligible for inclusion in the study) :

A) One or more of the following phenotypic criteria:

Significant unintentional weight loss: A weight loss of ≥ 5% within 1 month or ≥ 10% within 6 months Low Body Mass Index (BMI): BMI < 18.5 kg/m² for individuals under 70 years old, BMI < 21 kg/m² for individuals aged 70 years and older Reduced Muscle Mass Evident reduction in muscle mass AND

B) One of the following etiological criteria:

Inadequate nutritional intake:

Nutritional intake less than 50% of the energy requirements for more than one week Reduced food intake for more than two weeks Presence of Disease or Stress Metabolism Acute or chronic illness, or any condition causing metabolic stress that increases energy requirements

Treatment and study plan

Use of a powered alternating pressure air mattress

Device

Patients with a medium to high risk of developing pressure injury, without pressure injury, up during the day and lying between 15 and 20 hours per day will ly a on a R'GO Soins overlay mattress

Primary outcomes

  1. Percentage of patients who developed at least one stage 2 pressure injury

    Time frame: 35 days after installation on the mattress (at day 35)

    Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)

Secondary outcomes

  1. Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between

    Time frame: 35 days after installation on the mattress (at day 35)

  2. Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)

    Time frame: 35 days after installation on the mattress (at day 35)

    On a scale from 0 (not satisfied at all) to 4 (very satisfied)

  3. Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)

    Time frame: 35 days after installation on the mattress (at day 35)

    On a scale from 0 (not satisfied at all) to 4 (very satisfied)

  4. Assessment of the degree of maceration

    Time frame: 35 days after installation on the mattress (at day 35)

    On a scale from 1 (constantly moist) to 4 (rarely moist)

  5. Assessment of mattress safety

    Time frame: At day 35

    By collecting any adverse event or mattress malfunction during the follow up

Sponsors and collaborators

Lead sponsor

Nausicaa Medical

Industry

Collaborators

  • Clin-Experts

Registry information

Official study title

Prevention of Pressure Ulcers in Patients at Medium to High Risk of Pressure Ulcers Using the R'GO SOINS Overlay Mattress : Observational Study

Acronym: PRESERVE

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 18, 2024
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.